0001415889-23-000085.txt : 20230103
0001415889-23-000085.hdr.sgml : 20230103
20230103170321
ACCESSION NUMBER: 0001415889-23-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAUSEY CHRISTOPHER
CENTRAL INDEX KEY: 0001237334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 23503066
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-01032023_100101.xml
X0306
4
2023-01-03
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001237334
CAUSEY CHRISTOPHER
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
true
false
false
false
Common Stock
2023-01-03
4
M
0
1000
175.43
A
3835
D
Common Stock
2023-01-03
4
S
0
1000
276.26
D
2835
D
Stock Options
175.43
2023-01-03
4
M
0
1000
0
D
2016-06-26
2025-06-26
Common Stock
1000
3000
D
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
/s/ John S. Hess, Jr. under Power of Attorney
2023-01-03